As immunotherapy becoming the first-line treatment for advanced lung cancer, potential predictive biomarkers of immune checkpoint inhibitor (ICI), such as PD−L1, TMB and MSI, were also compared between biopsy and resection specimens in this study. The gene discussed is CD274; the disease is lung carcinoma.